Polynovo Limited
$1.72
34
+$0+0% Thursday 20:00
Statistics
Day High
1.65
Day Low
1.65
52W High
1.72
52W Low
0.4
Volume
100
Avg. Volume
1,396
Mkt Cap
1.14B
P/E Ratio
0
Dividend Yield
-
Dividend
-
Upcoming
Earnings
22AugConfirmed
Expected EPS
0.002499009810492962
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CALZF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Mimedx
MDXG
Mkt Cap1.06B
Icad
ICAD
Mkt Cap34.5M
Sanara MedTech
SMTI
Mkt Cap260.05M
Avinger
AVGR
Mkt Cap2.99M
Anika Therapeutics
ANIK
Mkt Cap402.03M
Integra Lifesciences
IART
Mkt Cap2.47B
Stryker
SYK
Mkt Cap129.88B
About
Biotechnology
Health Technology
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Show more...
CEO
Paul Brennan
Employees
237
Country
AU
ISIN
AU000000PNV0
WKN
000A12F4T